சுருள் சிரை நரம்பு சாதனம் சந்தை படிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சுருள் சிரை நரம்பு சாதனம் சந்தை படிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சுருள் சிரை நரம்பு சாதனம் சந்தை படிப்பு Today - Breaking & Trending Today

Evolution in Theraclion's Capital: Bernard Sabrier and Unigestion Pass the 20% Threshold, Proof of Confidence in the Company's Development


(0)
Regulatory News:
THERACLION (ISIN: FR0010120402; Memo: ALTHE, PEA-PME eligible), an innovative company specializing in ultrasound therapy (using High Intensity Focused Ultrasound or HIFU), announces that Bernard Sabrier and Unigestion, acting on their own behalf, have informed Theraclion that they have crossed the thresholds of 20% and 25% of the company s capital and voting rights. This situation results from the conversion of convertible bonds into shares and is a sign of confidence in Theraclion s capacity for innovation and development.
In addition to the provisions of the French Commercial Code and Theraclion s statutes, Bernard Sabrier s and Unigestion s increase in Theraclion s share capital comes at a time when the company is reaching a level of technological maturity with the development of SONOVEIN S for the non-invasive treatment of varicose veins, the rollout of ECHOPULSE for the treatment of thyroid nodules, and recent announcement in the treatment of ....

France General , Kostenloser Wertpapierhandel , Bernard Sabrier , David Caumartin , Anja Kleber , University Of Virginia United States , Unigestion Asia Pte Ltd , Regulatory News , High Intensity Focused Ultrasound , French Commercial Code , United Statesa , Unigestion Asia Pte , Children Action , Varicose Vein Device Market Study , Euronext Growth Paris , Executive Officer , Market Access Sales Francophonia , பிரான்ஸ் ஜநரல் , அஞ்ச கிலேபெர் , ஒழுங்குமுறை செய்தி , உயர் தீவிரம் கவனம் அல்ட்ராசவுண்ட் , பிரஞ்சு வணிகரீதியானது குறியீடு , குழந்தைகள் நடவடிக்கை , சுருள் சிரை நரம்பு சாதனம் சந்தை படிப்பு , நிர்வாகி அதிகாரி ,

THERACLION: Theraclion's Strategy Is in Place for 2021 Despite the Impact of Covid-19 on Sales Revenues For 2020


(1)
Regulatory News:
THERACLION (Paris:ALTHE) (ISIN: FR0010120402; Mnemo: ALTHE, PEA-PME eligible), an innovative company specializing in the development of medical equipment for echotherapy treatment, notably for varicose veins, today announces its sales revenues for the year 2020 and roll-out strategy for 2021.
Roll-out strategy 2021
SONOVEIN S, the last generation of SONOVEIN systems (CE marking obtained in Oct. 2020), makes SONOVEIN a strong alternative in treatment of varicose veins. It allows faster non-surgical treatment on an ambulatory basis without the need for anaestesia. Since October the company has made significant progress with their roll-out strategy. For 2021, it plans to further expand business development in new territories including Asia. Theraclion will also significantly increase SONOVEIN S installations at new key opinion leader sites. These international experts show strong interest in this distruptive technology. Once equipped, their cent ....

United States , France General , United Kingdom , City Of , Kostenloser Wertpapierhandel , David Auregan , Mark Whiteley , Anja Kleber , American Vein Lymphatic Society , Regulatory News , United Kingdom Venous Surgeon , High Intensity Focused Ultrasound , Varicose Vein Device Market Study , Euronext Growth Paris , Finance Officer , Market Access Sales Francophonia , Co Vid , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , குறி வைட்லி , அஞ்ச கிலேபெர் , அமெரிக்கன் நரம்பு நிணநீர் சமூகம் , ஒழுங்குமுறை செய்தி , ஒன்றுபட்டது கிஂக்டம் சிரை அறுவை சிகிச்சை நிபுணர் ,

Renewed Investor Confidence in Theraclion


Renewed Investor Confidence in Theraclion
Additional PGE loans for 1.5M€
Regulatory News:
THERACLION (Paris:ALTHE) (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company specialized in echotherapy treatment (using High Intensity Focused Ultrasound or HIFU) notably for varicose veins, announces today that it has raised €3.0 million from investors and obtaining PGE loans from Bpi France and CIC of €1.5 million.
€4.5 million in new funding allows Theraclion to stay ahead, whilst accelerating commercial rollout
In 2019 Theraclion raised first tranche of €4,8 million from investors to finance the further development of its SONOVEIN technology. This success culminated in the recent CE marking of SONOVEIN S, the second-generation breakthrough technology for non-invasive treatment of varicose veins (please see press release of October 15th this year). Initial treatments with our technological breakthroughs also confirm excellent clinical results and were ....

France General , Kostenloser Wertpapierhandel , David Caumartin , Anja Kleber , High Intensity Focused Ultrasound , Bpi France , Varicose Vein Device Market Study , Euronext Growth Paris , Executive Officer , Market Access Sales Francophonia , பிரான்ஸ் ஜநரல் , அஞ்ச கிலேபெர் , உயர் தீவிரம் கவனம் அல்ட்ராசவுண்ட் , பிபி பிரான்ஸ் , சுருள் சிரை நரம்பு சாதனம் சந்தை படிப்பு , நிர்வாகி அதிகாரி ,